FN
Fabrinet
FN's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over FN overall, supported by stronger valuation and stronger fundamentals.
FN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Under pressure | |
| Strong |
FN's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
FN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $354 | — |
| Cheap | 19x | $258 | -27% |
| Fair | 25x | $335 | -5.4% |
| Current | 27x | $354 | — |
| Expensive | 33x | $437 | +23% |
Historical ranges are pointers, not guarantees.
FN's PE is in its fair range at 27x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over FN in the historical PE scenario, which offers more potential upside but is not a forecast.
FN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| High |
FN has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
FN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.94 | +58% |
| Q3 2026 | $13.25 | +37% |
| Q2 2026 | $13.05 | +42% |
| Q1 2026 | $11.63 | +30% |
| Q4 2025 | $10.43 | +17% |
| Q3 2025 | $9.70 | +15% |
| Q2 2025 | $9.17 | +13% |
| Q1 2025 | $8.98 | +19% |
| Q4 2024 | $8.94 | +29% |
FN's earnings per share have climbed steadily: $13.25 over the past year, up 37% from the year before, and higher year over year every quarter since late 2020.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over FN on earnings, with stronger typical year-over-year growth.
FN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +51% |
| Q2 2026 | $1.3B | +45% |
| Q1 2026 | $1.2B | +39% |
| Q4 2025 | $1.1B | +36% |
| Q3 2025 | $978.1M | +22% |
| Q2 2025 | $909.7M | +21% |
| Q1 2025 | $871.8M | +19% |
| Q4 2024 | $833.6M | +17% |
FN's revenue has grown year over year every quarter since late 2020: $1.5B last quarter, up 51% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.9% | +0.3 points |
| Q2 2026 | 10% | +0.4 points |
| Q1 2026 | 9.9% | +0.8 points |
| Q4 2025 | 10% | +0.5 points |
| Q3 2025 | 9.6% | +0.1 points |
| Q2 2025 | 9.8% | +0.1 points |
| Q1 2025 | 9.1% | -0.7 points |
| Q4 2024 | 9.6% | -0.1 points |
FN's operating margin was 9.9% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over FN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over FN on profitability, with a higher operating margin.
FN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$137.4M | -340% |
| Q2 2026 | -$36.9M | -888% |
| Q1 2026 | -$10.8M | -124% |
| Q4 2025 | -$5.3M | -106% |
| Q3 2025 | $57.3M | -8.9% |
| Q2 2025 | $4.7M | -93% |
| Q1 2025 | $45.7M | -48% |
| Q4 2024 | $94M | +26% |
FN's free cash flow has turned negative after years in the green: −$190M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over FN on cash generation, producing positive trailing cash flow while its opponent burns cash.
FN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -19K shares |
| 1 year | +0.4% | +136K shares |
| 3 years | -0.7% | -248K shares |
| 5 years | -2.9% | -1.1M shares |
| Available history | -4.1% | -1.5M shares |
FN has 36M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $29.1M |
| Q2 2026 | — |
| Q1 2026 | $151,000 |
| Q4 2025 | $4.8M |
| Q3 2025 | $268,000 |
| Q2 2025 | $22.3M |
| Q1 2025 | $34.8M |
| Q2 2024 | $3.5M |
FN spent $34M buying back its own shares over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over FN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
FN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
FN has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
FN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.3 | Neutral |
| Stochastic | 13.9 | Oversold |
FN's weekly RSI is 40 (neutral) and its Stochastic is 14 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
FN PE vs Technology Sector
| Metric | FN | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 4.2% below |
| PE % | 60 | 35 | 25 pts above |
FN is trading at 27x earnings, in line with the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over FN on valuation relative to its sector.
FN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $381.8 | 7.3% below |
| 20 week MA | $430.4 | 18% below |
| 50 week MA | $508.0 | 30% below |
| 100 week MA | $396.1 | 11% below |
| 200 week MA | $287.6 | 23% above |
FN has fallen below most of its moving averages, though it's still 23% above its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
FN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $64.6 | $76.1 | +18% |
| 2021 | $76.1 | $118.0 | +55% |
| 2022 | $118.0 | $128.7 | +9% |
| 2023 | $128.7 | $190.3 | +48% |
| 2024 | $190.3 | $219.5 | +15% |
| 2025 | $219.5 | $478.3 | +118% |
| 2026 YTD | $478.3 | $353.8 | -26% |
FN has finished every year since 2020 higher, and it's down 26% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over FN on returns for 2026, with the stronger performance.